Furthermore, the prospective Baltimore Longitudinal Study has shown that impairments in brain glucose uptake are correlated with the reduced expression of the GLUT3 glucose transporter and subsequent development of AD (An et al., 2018). Here, SLC2A3 is linked to Alzheimer disease.